Annual Net Margin
-110.85%
+17.68%+13.76%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual net profit margin is -110.85%, with the most recent change of +17.68% (+13.76%) on April 30, 2024.
- During the last 3 years, IPA annual net margin has fallen by -69.87% (-170.50%).
- IPA annual net margin is now -215.00% below its all-time high of -35.19%, reached on April 30, 2020.
Performance
IPA Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-41.68%
+34.30%+45.14%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly net profit margin is -41.68%, with the most recent change of +34.30% (+45.14%) on October 31, 2024.
- Over the past year, IPA quarterly net margin has increased by +34.30% (+45.14%).
- IPA quarterly net margin is now -327.05% below its all-time high of -9.76%, reached on October 31, 2020.
Performance
IPA Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
IPA Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.8% | +45.1% |
| 3 y3 years | -170.5% | +45.1% |
| 5 y5 years | -59.0% | +45.1% |
IPA Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -170.5% | +13.8% | -6.4% | +85.1% |
| 5 y | 5-year | -215.0% | +13.8% | -327.1% | +85.1% |
| alltime | all time | -215.0% | +100.0% | -327.1% | +100.0% |
ImmunoPrecise Antibodies Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | -41.68%(-45.1%) |
| Jul 2024 | - | -75.98%(-72.8%) |
| Apr 2024 | -110.85%(-13.8%) | -279.38%(+491.2%) |
| Jan 2024 | - | -47.26%(+20.7%) |
| Oct 2023 | - | -39.17%(-34.8%) |
| Jul 2023 | - | -60.06%(-34.2%) |
| Apr 2023 | -128.53%(+49.0%) | -91.25%(+0.4%) |
| Jan 2023 | - | -90.87%(-35.9%) |
| Oct 2022 | - | -141.80%(-29.1%) |
| Jul 2022 | - | -200.06%(+125.7%) |
| Apr 2022 | -86.29%(+110.6%) | -88.64%(+11.6%) |
| Jan 2022 | - | -79.46%(-25.1%) |
| Oct 2021 | - | -106.08%(+50.7%) |
| Jul 2021 | - | -70.40%(-31.8%) |
| Apr 2021 | -40.98%(+16.5%) | -103.20%(+260.1%) |
| Jan 2021 | - | -28.66%(+193.6%) |
| Oct 2020 | - | -9.76%(-33.1%) |
| Jul 2020 | - | -14.58%(-36.1%) |
| Apr 2020 | -35.19%(-49.5%) | -22.81%(+47.1%) |
| Jan 2020 | - | -15.51%(-64.0%) |
| Oct 2019 | - | -43.12%(-41.8%) |
| Jul 2019 | - | -74.08%(-49.1%) |
| Apr 2019 | -69.72%(-26.6%) | -145.48%(+230.3%) |
| Jan 2019 | - | -44.04%(-19.5%) |
| Oct 2018 | - | -54.69%(+42.5%) |
| Jul 2018 | - | -38.37%(-68.4%) |
| Apr 2018 | -95.03%(-53.6%) | -121.41%(+72.7%) |
| Jan 2018 | - | -70.31%(+2.5%) |
| Oct 2017 | - | -68.62%(-52.7%) |
| Jul 2017 | - | -145.13%(-27.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2017 | -204.67%(-99.7%) | -201.31%(-76.8%) |
| Jan 2017 | - | -868.63%(+6696.8%) |
| Sep 2008 | - | -12.78%(-87.5%) |
| Sep 2007 | - | -101.92%(-97.9%) |
| Jun 2006 | - | -4755.54%(+112.9%) |
| Sep 2005 | - | -2233.76%(+95.2%) |
| Jun 2005 | - | -1144.39%(+448.6%) |
| Sep 2004 | - | -208.62%(-78.7%) |
| Jun 2004 | - | -980.13%(-98.8%) |
| Dec 2001 | -61.07 K%(+49.9%) | - |
| Jun 2001 | - | -79.20 K%(-96.9%) |
| Mar 2001 | - | -2.58 M%(>+9900.0%) |
| Dec 2000 | -40.74 K%(+148.2%) | - |
| Dec 2000 | - | -11.68 K%(-99.2%) |
| Sep 2000 | - | -1.52 M%(-40.9%) |
| Jun 2000 | - | -2.58 M%(+6.6%) |
| Mar 2000 | - | -2.42 M%(>+9900.0%) |
| Dec 1999 | -16.41 K%(+592.1%) | - |
| Dec 1999 | - | -16.11 K%(-98.8%) |
| Jun 1999 | - | -1.35 M%(-64.5%) |
| Mar 1999 | - | -3.82 M%(>+9900.0%) |
| Dec 1998 | -2371.69%(-99.8%) | - |
| Dec 1998 | - | -2150.01%(-99.6%) |
| Sep 1998 | - | -489.30 K%(-86.1%) |
| Jun 1998 | - | -3.53 M%(-13.8%) |
| Mar 1998 | - | -4.09 M%(+248.7%) |
| Dec 1997 | -1.31 M%(>+9900.0%) | - |
| Dec 1997 | - | -1.17 M%(-53.9%) |
| Sep 1997 | - | -2.54 M%(-56.9%) |
| Jun 1997 | - | -5.90 M% |
| Dec 1996 | -11.04 K% | - |
FAQ
- What is ImmunoPrecise Antibodies annual net profit margin?
- What is the all time high annual net margin for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual net margin year-on-year change?
- What is ImmunoPrecise Antibodies quarterly net profit margin?
- What is the all time high quarterly net margin for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly net margin year-on-year change?
What is ImmunoPrecise Antibodies annual net profit margin?
The current annual net margin of IPA is -110.85%
What is the all time high annual net margin for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual net profit margin is -35.19%
What is ImmunoPrecise Antibodies annual net margin year-on-year change?
Over the past year, IPA annual net profit margin has changed by +17.68% (+13.76%)
What is ImmunoPrecise Antibodies quarterly net profit margin?
The current quarterly net margin of IPA is -41.68%
What is the all time high quarterly net margin for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly net profit margin is -9.76%
What is ImmunoPrecise Antibodies quarterly net margin year-on-year change?
Over the past year, IPA quarterly net profit margin has changed by +34.30% (+45.14%)